Psychiatry Research: Neuroimaging
Volume 148, Issue 2 , Pages 195-203 , 1 December 2006

Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy

  • Erik Ryding

      Affiliations

    • Section of Clinical Neurophysiology, Department of Neuroscience, University of Lund, University Hospital, Lund, Sweden
    • Corresponding Author InformationCorresponding author. Department of Clinical Neurophysiology, Karolinska University Hospital, Huddinge, SE-141 86 Stockholm, Sweden. Tel.: +46 858587283; fax: +46 87748856.
    • ,
  • Jan-Anders Ahnlide

      Affiliations

    • Section of Clinical Neurophysiology, Department of Neuroscience, University of Lund, University Hospital, Lund, Sweden
    • ,
  • Mats Lindström

      Affiliations

    • Section of Psychiatry, Department of Neuroscience, University of Lund, University Hospital, Lund, Sweden
    • ,
  • Ingmar Rosén

      Affiliations

    • Section of Clinical Neurophysiology, Department of Neuroscience, University of Lund, University Hospital, Lund, Sweden
    • ,
  • Lil Träskman-Bendz

      Affiliations

    • Section of Psychiatry, Department of Neuroscience, University of Lund, University Hospital, Lund, Sweden

Received 20 January 2006 ,Revised 7 June 2006 ,Accepted 7 June 2006.

References 

  1. Ågren H, Mefford I, Rudorfer M, Linnoila M, Potter W. Interacting neurotransmitter systems. A non-experimental approach to the 5-HIAA-HVA correlation in human CSF. Psychiatry Research. 1986;20:175–193
  2. Allard P, Norlen M. Unchanged density of caudate nucleus dopamine uptake sites in depressed suicide victims. Journal of Neural Transmission. 1997;104:1353–1360
  3. Allard P, Norlen M. Caudate nucleus dopamine D2 receptors in depressed suicide victims. Neuropsychobiology. 2001;44:70–73
  4. Arango V, Underwood M, Mann J. Postmortem findings in suicide victims. Implications for in vivo imaging studies. Annals of the New York Academy of Sciences. 1997;836:269–287
  5. Arató M, Tekes K, Tothfalusi L, Magyar K, Palkovits M, Demeter E, et al. Serotonergic split brain and suicide. Psychiatry Research. 1987;21:335–336
  6. Arató M, Frecska E, MacCrimmon D, Guscott R, Saxena B, Tekes K, et al. Serotonergic interhemispheric asymmetry: neurochemical and pharmaco-EEG evidence. Programs of Neuropsychopharmachology and Biological Psychiatry. 1991;15:759–764
  7. Arora R, Meltzer H. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. American Journal of Psychiatry. 1989;146:730–736
  8. Åsberg M, Montgomery S, Perris C, Schalling D, Sedvall G. CPRS — the Comprehensive Psychopathological Rating Scale. Acta Psychiatrica Scandinavica. Supplementum. 1978;271:5–27
  9. Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, van Heeringen C, et al. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients. European Journal of Nuclear Medicine. 2001;28:175–182
  10. Audenaert K, Goethals I, Van Laere K, Lahorte P, Brans B, Versijpt J, et al. SPECT neuropsychological activation procedure with the Verbal Fluency Testing in attempted suicide patients. Nuclear Medicine Communications. 2002;23:907–916
  11. Bauman P, Larsen F. The pharmacokinetics of citalopram. Contemporary Pharmacotherapy. 1995;287–295
  12. Beck A, Herman I, Schuyler D. Development of suicidal intent scales. In:  Beck A,  Resnik H,  Lettieri D editor. The Prediction of Suicide. Bowie, MD: Charles Press; 1974;p. 45–56
  13. Berlin H, Rolls E, Kischka U. Impulsiveness, time perception, emotion and reinforcement sensitivity in patients with orbitofrontal cortex lesions. Brain. 2004;172:1108–1126
  14. Catenoix H, Magnin M, Guenot M, Isnard J, Mauguiere F, Ryvlin P. Hippocampal-orbitofrontal connectivity in human: an electrical stimulation study. Clinical Neurophysiology. 2005;116:1779–1784
  15. Dahlstrom M, Ahonen A, Ebeling H, Torniainen P, Heikkila J, Moilanen I. Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naïve children and adolescents. Molecular Psychiatry. 2000;5:514–522
  16. Demeter E, Tekes K, Majorossy K, Palkovits M, Soos M, Magyar K, et al. The asymmetry of 3H-imipramine binding may predict psychiatric illness. Life Sciences. 1989;44:1403–1410
  17. DSM IV; American Psychiatric Association (APA) . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: (DSM-IV) APA; 1994;
  18. Engström G, Alling C, Oreland L, Träskman-Bendz L. The Marke–Nyman Temperament (MNT) scale in relationship with monoamine metabolism and corticosteroid measures in suicide attempters. Archives of Suicide Research. 1996;2:145–159
  19. Engström G, Nyman G, Träskman-Bendz L. The Marke–Nyman (MNT) scale in suicide attempters. Acta Psychiatrica Scandinavica. 1996;94:320–325
  20. Engström G, Alling C, Blennow K, Regnéll G, Träskman-Bendz L. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. European Journal of Neuropsychopharmacology. 1999;9:399–405
  21. Frankle W, Lombardo I, New A, Goodman M, Talbot P, Huang Y, et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. American Journal of Psychiatry. 2005;162:915–923
  22. Fuster J, Bauer R, Jervey J. Functional interactions between inferotemporal and prefrontal cortex in a cognitive task. Brain Research. 1985;330:299–307
  23. Goethals I, Audenaert K, Jacobs F, Van den Eynde F, Bernagie K, Kolindou A, et al. Brain perfusion SPECT in impulsivity-related personality disorders. Behavioural Brain Research. 2005;157:187–192
  24. Gross-Isserdorf R, Israeli M, Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Archives of General Psychiatry. 1989;46:237–241
  25. Hrdina P, Demeter E, Vu T, Sotonyi P, Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Research. 1993;614:37–44
  26. Kretschmann H, Weirich W. Neuroanatomy and Cranial Computed Tomography. Stuttgart: Thieme Verlag; 1986;
  27. Kuikka J, Tiihonen J, Bergström K, Karhu J, Hartikainen P, Viinamäki H, et al. Imaging of serotonin and dopamine transporters in the living human brain. European Journal of Nuclear Medicine. 1995;22:346–350
  28. Laasonen-Balk T, Kuikka J, Viinamaki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J. Striatal dopamine transporter density in major depression. Psychopharmacology (Berlin). 1999;144:282–285
  29. Laruelle M, Baldwin R, Malison R, Zea-Ponce Y, Zoghbi S, al-Tikriti M, et al. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse. 1993;13:295–309
  30. Laruelle M, Wallace E, Seibyl J, Zea-Ponce Y, Zoghbi S, Neumeier J, et al. Graphical, kinetic, and equilibrium analyses of in vivo [123-I]-beta-CIT binding to dopamine transporters in healthy human subjects. Journal of Cerebral Blood Flow and Metabolism. 1994;14:982–994
  31. Lawrence K, De Paermentier F, Cheetham S, Crompton M, Katona C, Horton R. Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides. Brain Research. 1990;526:17–22
  32. Leake A, Fairbairn A, McKeith I, Ferrier I. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates. Psychiatry Research. 1991;39:155–165
  33. Lindström M, Ryding E, Bosson P, Ahnlide J-A, Rosén I, Träskman-Bendz L. Impulsiveness related to brain serotonin transporter binding capacity in suicide attempters. European Neuropsychopharmacology. 2004;14:295–300
  34. Lowther S, de Paermentier F, Cheetham S, Crompton M, Katona C, Horton R. 5HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. Journal of Affective Disorders. 1997;42:199–207
  35. Mann J, Huang Y, Underwood M, Kassir S, Oppenheim S, Kelly T, et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Archives of General Psychiatry. 2000;57:739–740
  36. Montgomery S, Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry. 1979;134:382–389
  37. Meyer J, Houle S, Sagrati S, Carella A, Hussey D, Ginovart N, et al. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Archives of General Psychiatry. 2004;61:1271–1279
  38. Niméus A, Alsén M, Träskman-Bendz L. Do high suicide intent scores indicate future suicide?. Archives of Suicide Research. 2002;6:211–220
  39. Newberg A, Amsterdam J, Wintering N, Ploessl K, Swanson R, Shults J, et al. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. Journal of Nuclear Medicine. 2005;46:973–977
  40. Owen F, Chambers D, Cooper S, Crow T, Johnson J, Lofthouse R, et al. Serotonergic mechanisms in brains of suicide victims. Brain Research. 1986;362:185–188
  41. Parsey R, Hastings R, Oquendo M, Huang Y, Simpson N, Arcement J, et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes. American Journal of Psychiatry. 2006;163:8–11
  42. Pitchot W, Reggers J, Pinto E, Hansenne M, Fuchs S, Pirard S, et al. Reduced dopaminergic activity in depressed suicides. Psychoneuroendocrinology. 2001;26:331–335
  43. Pitchot W, Hansenne M, Gonzalez Moreno A, Pinto E, Reggers J, Fuchs S, et al. Reduced dopamine function in depressed patients is related to suicidal behaviour but not its lethality. Psychoneuroendocrinology. 2001;26:689–696
  44. Pitchot W, Hansenne M, Ansseau M. Role of dopamine in non-depressed patients with a history of suicide attempts. European Psychiatry. 2001;16:424–427
  45. Pitchot W, Reggers J, Pinto E, Hansenne M, Ansseau M. Catecholamine and HPA axis dysfunction in depression: relationship with suicidal behaviour. Neuropsychobiology. 2003;47:152–157
  46. Ryding E, Lindström M, Bradvik B, Grabowski M, Bosson P, Träskman-Bendz L, et al. A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence. European Journal of Nuclear Medicine and Molecular Imaging. 2004;31:1114–1118
  47. Sjöbring H. Personality structure and development — a model and its application. Acta Psychiatrica Scandinavica. Supplementum. 1973;244:113–157
  48. Stanley M, Mann J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet. 1983;1:214–216
  49. Tauscher J, Pirker W, Willeit M, Zwaan M, Bailer U, Neumeister A, et al. [123I]-beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biological Psychiatry. 2001;49:236–332
  50. Tiihonen J, Kuikka J, Bergstrom K, Karhu J, Viinamaki H, Lehtonen J, et al. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour. European Journal of Nuclear Medicine. 1997;24:1253–1260
  51. Träskman-Bendz L, Mann J. Biological aspects of suicidal behaviour. In:  Hawton K,  van Heeringen K editor. The International Handbook of Suicide and Attempted Suicide. Chichester, UK: Wiley; 2000;p. 65–77
  52. van Heeringen C, Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, et al. Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. Journal of Affective Disorders. 2003;74:149–158
  53. Willeit M, Praschak-Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O, et al. [123-I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biological Psychiatry. 2000;47:482–489
  54. Winstanley C, Theobald D, Cardinal R, Robbins T. Contrasting roles of basolateral amygdala and orbitfrontal cortex in impulsive choice. Journal of Neuroscience. 2004;24:4718–4722
  55. World Health Organization (WHO) . The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: WHO; 1993;
  56. Zalsman G, Anderson G, Peskin M, Frisch A, King R, Vekslerchik M, et al. Relationships between serotonin transporter promoter polymorphism, platelet serotonin transporter binding and clinical phenotype in suicidal and non-suicidal inpatients. Journal of Neural Transmission. 2005;112:309–315

PII: S0925-4927(06)00099-0

doi: 10.1016/j.pscychresns.2006.06.001

Psychiatry Research: Neuroimaging
Volume 148, Issue 2 , Pages 195-203 , 1 December 2006

Article Tools

* Image Usage & Resolution